Short Interest in Check-Cap Ltd. (NASDAQ:CHEK) Grows By 7.6%

Check-Cap Ltd. (NASDAQ:CHEK) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 9,900 shares, a growth of 7.6% from the November 30th total of 9,200 shares. Based on an average trading volume of 690,100 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.2% of the shares of the company are short sold.

Check-Cap Trading Down 13.9 %

CHEK traded down $0.16 on Wednesday, reaching $0.99. The stock had a trading volume of 173,603 shares, compared to its average volume of 257,456. The company has a market cap of $5.79 million, a P/E ratio of -0.33 and a beta of 0.25. The business’s 50-day moving average price is $0.94 and its two-hundred day moving average price is $1.51. Check-Cap has a 12-month low of $0.56 and a 12-month high of $3.45.

Analyst Upgrades and Downgrades

Separately, StockNews.com began coverage on shares of Check-Cap in a research note on Friday, December 27th. They set a “sell” rating on the stock.

Check-Cap Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.